Center for Alcohol and Addiction Studies, Brown University.
Department of Psychological Sciences, Purdue University.
J Consult Clin Psychol. 2019 Oct;87(10):872-886. doi: 10.1037/ccp0000402.
Prescribed opioids for chronic pain management contribute significantly to the opioid crisis. There is a need to understand the real-world benefits that, despite risks, lead chronic pain patients to persist in opioid use. Negative reinforcement models of addiction posit that individuals use substances to reduce aversive states but have seldom been applied to prescribed opioids. Using ecological momentary assessment, we examined reciprocal associations between opioid use and physical pain, for which opioids are prescribed, and negative affect (NA), for which they are not.
Chronic low back pain patients on long-term opioid therapy (n = 34) without significant past-year opioid misuse reported multiple times daily via smartphone over 2 weeks (nobservations = 2,285). We hypothesized that pain and NA would be positively associated with subsequent opioid use, and that use would be negatively associated with subsequent pain and NA.
Time-lagged multilevel models indicated that participants were more likely to use opioids and in larger doses following elevated pain and NA. There was also an interaction of concurrent pain and NA on opioid dose. In turn, participants reported reduced pain and NA following larger doses. Additionally, individuals at high risk for opioid misuse, compared with low risk, took larger doses following pain, but also experienced smaller subsequent pain and NA reductions.
Opioid use was bidirectionally associated with pain and NA. Findings fit negative reinforcement models associated with risk of developing opioid use disorder. Educating patients and providers about negative reinforcement may help reduce opioid use and opioid-associated risks. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
用于慢性疼痛管理的处方类阿片类药物是阿片类药物危机的主要原因。我们需要了解尽管存在风险,但仍使慢性疼痛患者坚持使用阿片类药物的真实获益。成瘾的负强化模型认为,个体使用物质是为了减轻痛苦状态,但很少将其应用于处方类阿片类药物。本研究使用生态瞬时评估,考察了阿片类药物使用与身体疼痛(阿片类药物用于治疗的疾病)和负性情绪(阿片类药物不用于治疗的疾病)之间的相互关系。
慢性低背痛患者接受长期阿片类药物治疗(无显著的过去一年阿片类药物滥用史),在 2 周内通过智能手机多次每日报告(n 观察=2285)。我们假设疼痛和负性情绪与随后的阿片类药物使用呈正相关,而使用与随后的疼痛和负性情绪呈负相关。
时滞多层模型表明,参与者在疼痛和负性情绪升高后更有可能使用阿片类药物且剂量更大。同时疼痛和负性情绪对阿片类药物剂量也存在交互作用。反过来,参与者报告在使用较大剂量后疼痛和负性情绪减轻。此外,与低风险者相比,高风险者在疼痛后使用更大剂量,但随后疼痛和负性情绪的减轻幅度较小。
阿片类药物的使用与疼痛和负性情绪呈双向关联。研究结果符合与阿片类药物使用障碍风险相关的负强化模型。教育患者和医务人员了解负强化可能有助于减少阿片类药物的使用和阿片类药物相关风险。